Lundbeck
| Use attributes for filter ! | |
| Stock price | LUN |
|---|---|
| Disclaimer | |
| Headquarters | Copenhagen |
| Denmark | |
| Ceo | Deborah Dunsire |
| Revenue | 17. 2 billion DKK (2017) |
| Subsidiaries | Abide Therapeutics Inc. |
| Prexton Therapeutics SA | |
| Address | FSM mah. Poligon cad. Buyaka 2 Sitesi No: 8A kat 7 İstanbul TR, 34771 Ümraniye |
| Hours | Closed ⋅ Opens 8AM Mon |
| Phone | (0216) 538 96 00 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844829 |
About Lundbeck
H. Lundbeck A/S is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system, including depression, schizophrenia, Alzheimer's disease and Parkinson's disease.
Where is the Lundbeck
Click on the photo of Lundbeck to view it on Google Maps.
